LRCOL1
gene geneOn this page
Summary
LRCOL1 (leucine rich colipase like 1, HGNC:44160) is a protein-coding gene on chromosome 12q24.33, encoding Leucine-rich colipase-like protein 1 (A6NCL2).
Predicted to enable enzyme activator activity. Predicted to be involved in digestion and lipid catabolic process. Predicted to be located in extracellular region.
Source: NCBI Gene 100507055 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 29 total
- MANE Select transcript:
NM_001195520
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:44160 |
| Approved symbol | LRCOL1 |
| Name | leucine rich colipase like 1 |
| Location | 12q24.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000204583 |
| Ensembl biotype | protein_coding |
| Entrez | 100507055 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 3 protein_coding, 3 nonsense_mediated_decay, 2 retained_intron
ENST00000376608, ENST00000536100, ENST00000544018, ENST00000545517, ENST00000616042, ENST00000622710, ENST00000880637, ENST00000880638
RefSeq mRNA: 1 — MANE Select: NM_001195520
NM_001195520
CCDS: CCDS73547
Canonical transcript exons
ENST00000376608 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001616099 | 132606147 | 132606264 |
| ENSE00002220581 | 132603151 | 132603404 |
| ENSE00002283583 | 132604706 | 132604831 |
| ENSE00003589582 | 132604462 | 132604584 |
| ENSE00003651166 | 132604254 | 132604376 |
| ENSE00003850351 | 132610323 | 132610582 |
Expression profiles
Bgee: expression breadth ubiquitous, 120 present calls, max score 89.32.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1420 / max 95.4458, expressed in 38 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 134220 | 0.0566 | 17 |
| 134217 | 0.0443 | 7 |
| 134218 | 0.0386 | 8 |
| 134219 | 0.0026 | 1 |
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 89.32 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.07 | silver quality |
| right uterine tube | UBERON:0001302 | 85.34 | gold quality |
| liver | UBERON:0002107 | 83.87 | gold quality |
| right lung | UBERON:0002167 | 77.73 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 76.99 | gold quality |
| metanephros cortex | UBERON:0010533 | 71.45 | gold quality |
| fallopian tube | UBERON:0003889 | 70.73 | gold quality |
| lung | UBERON:0002048 | 70.04 | gold quality |
| left uterine tube | UBERON:0001303 | 68.65 | gold quality |
| spleen | UBERON:0002106 | 68.42 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 65.65 | gold quality |
| lymph node | UBERON:0000029 | 65.51 | gold quality |
| placenta | UBERON:0001987 | 65.09 | gold quality |
| ectocervix | UBERON:0012249 | 65.06 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 64.90 | gold quality |
| endocervix | UBERON:0000458 | 64.70 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 62.59 | gold quality |
| thyroid gland | UBERON:0002046 | 62.57 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 62.42 | gold quality |
| small intestine | UBERON:0002108 | 61.30 | gold quality |
| body of uterus | UBERON:0009853 | 61.07 | gold quality |
| lower esophagus | UBERON:0013473 | 60.76 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 60.73 | gold quality |
| uterine cervix | UBERON:0000002 | 60.49 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 60.47 | gold quality |
| right adrenal gland | UBERON:0001233 | 60.38 | gold quality |
| myometrium | UBERON:0001296 | 59.50 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 59.47 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 59.06 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.95 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
5 targeting LRCOL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-7156-5P | 99.64 | 68.81 | 1369 |
| HSA-MIR-4273 | 99.45 | 67.93 | 1206 |
| HSA-MIR-661 | 99.09 | 65.94 | 2062 |
| HSA-MIR-1292-3P | 72.98 | 63.40 | 23 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Lrcol1 | ENSMUSG00000072754 |
| rattus_norvegicus | Lrcol1 | ENSRNOG00000037466 |
Paralogs (3): CLPS (ENSG00000137392), CLPSL2 (ENSG00000196748), CLPSL1 (ENSG00000204140)
Protein
Protein identifiers
Leucine-rich colipase-like protein 1 — A6NCL2 (reviewed: A6NCL2)
All UniProt accessions (4): A0A087WT69, A0A087WYD7, A0A087WZ94, A6NCL2
RefSeq proteins (1): NP_001182449* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001981 | Colipase | Family |
Pfam: PF15083
UniProt features (5 total): sequence conflict 2, signal peptide 1, chain 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NCL2-F1 | 82.05 | 0.19 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 31
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 18 (showing top):
GOBP_DIGESTION, GOBP_LIPID_METABOLIC_PROCESS, GOBP_LIPID_CATABOLIC_PROCESS, chr12q24, GOMF_ENZYME_ACTIVATOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, CHEN_METABOLIC_SYNDROM_NETWORK, MIKKELSEN_MEF_LCP_WITH_H3K27ME3, MIKKELSEN_IPS_LCP_WITH_H3K4ME3, MIKKELSEN_ES_LCP_WITH_H3K4ME3, FOSTER_KDM1A_TARGETS_UP, ZNF331_TARGET_GENES, MIR661, DESCARTES_FETAL_LUNG_LYMPHATIC_ENDOTHELIAL_CELLS, MYOCD_TARGET_GENES
GO Biological Process (2): digestion (GO:0007586), lipid catabolic process (GO:0016042)
GO Molecular Function (1): enzyme activator activity (GO:0008047)
GO Cellular Component (1): extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| multicellular organismal process | 1 |
| lipid metabolic process | 1 |
| catabolic process | 1 |
| catalytic activity | 1 |
| enzyme regulator activity | 1 |
| molecular function activator activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
60 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LRCOL1 | SPMIP4 | Q8N865 | 705 |
| LRCOL1 | FAM229B | Q4G0N7 | 703 |
| LRCOL1 | NYAP1 | Q6ZVC0 | 665 |
| LRCOL1 | FSCB | Q5H9T9 | 595 |
| LRCOL1 | LELP1 | Q5T871 | 582 |
| LRCOL1 | CABS1 | Q96KC9 | 581 |
| LRCOL1 | SPATA24 | Q86W54 | 581 |
| LRCOL1 | EDDM3B | P56851 | 568 |
| LRCOL1 | TMEM114 | B3SHH9 | 533 |
| LRCOL1 | DRC11 | Q86XH1 | 520 |
| LRCOL1 | NAB2 | Q15742 | 512 |
| LRCOL1 | MYH15 | Q9Y2K3 | 462 |
| LRCOL1 | ABTB1 | Q969K4 | 448 |
| LRCOL1 | IFT56 | A0AVF1 | 446 |
| LRCOL1 | RNF13 | O43567 | 412 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A6NCL2, D3ZTT2, O19131, O46655, O70280, P01177, P01178, P01179, P01180, P01183, P01185, P01186, P03973, P13389, P19438, P22298, P22934, P25118, P35454, P35455, P50555, P58658, P58659, Q02509, Q14AE4, Q32LD3, Q3URS3, Q5T700, Q68US5, Q6UWE3, Q6UWL2, Q6V9X0, Q6WN34, Q76LW6, Q86Y78, Q8BPP5, Q8BVP6, Q8N6Q3, Q8VEA6, Q8WXA2
Diamond homologs: A6NCL2, Q3URS3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
29 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 26 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1072 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:132607206:T:TA | donor_gain | 1.0000 |
| 12:132604580:TTGGG:T | acceptor_gain | 0.9800 |
| 12:132604585:C:CC | acceptor_gain | 0.9800 |
| 12:132604708:T:TA | donor_gain | 0.9800 |
| 12:132604581:TGGG:T | acceptor_gain | 0.9700 |
| 12:132605014:CGGGG:C | acceptor_gain | 0.9700 |
| 12:132605287:G:GT | donor_gain | 0.9700 |
| 12:132606262:GACCT:G | acceptor_loss | 0.9700 |
| 12:132606263:ACCTG:A | acceptor_loss | 0.9700 |
| 12:132606265:C:CA | acceptor_loss | 0.9700 |
| 12:132606266:T:A | acceptor_loss | 0.9700 |
| 12:132606267:G:C | acceptor_loss | 0.9700 |
| 12:132607219:T:TA | donor_gain | 0.9600 |
| 12:132610282:C:A | donor_gain | 0.9600 |
| 12:132605019:C:CC | acceptor_gain | 0.9500 |
| 12:132610319:CTACC:C | donor_loss | 0.9500 |
| 12:132610320:TAC:T | donor_loss | 0.9500 |
| 12:132610321:ACC:A | donor_loss | 0.9500 |
| 12:132610322:C:A | donor_loss | 0.9500 |
| 12:132604377:C:CC | acceptor_gain | 0.9400 |
| 12:132606265:C:CC | acceptor_gain | 0.9400 |
| 12:132610317:CCCTA:C | donor_loss | 0.9400 |
| 12:132610318:CCTAC:C | donor_loss | 0.9400 |
| 12:132604582:GGG:G | acceptor_gain | 0.9300 |
| 12:132605016:GGGC:G | acceptor_loss | 0.9300 |
| 12:132605018:GCTGA:G | acceptor_loss | 0.9300 |
| 12:132605019:C:CA | acceptor_loss | 0.9300 |
| 12:132605020:T:G | acceptor_loss | 0.9300 |
| 12:132606139:GCAC:G | donor_loss | 0.9300 |
| 12:132606140:CACC:C | donor_loss | 0.9300 |
AlphaMissense
1039 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:132604294:C:G | C146S | 0.992 |
| 12:132604295:A:T | C146S | 0.992 |
| 12:132604468:C:A | W116C | 0.992 |
| 12:132604468:C:G | W116C | 0.992 |
| 12:132604550:C:G | C89S | 0.992 |
| 12:132604551:A:T | C89S | 0.992 |
| 12:132604712:C:A | W75C | 0.991 |
| 12:132604712:C:G | W75C | 0.991 |
| 12:132604342:C:G | C130S | 0.990 |
| 12:132604343:A:T | C130S | 0.990 |
| 12:132604505:C:G | C104S | 0.989 |
| 12:132604506:A:T | C104S | 0.989 |
| 12:132604265:A:G | C156R | 0.988 |
| 12:132604360:C:G | C124S | 0.987 |
| 12:132604361:A:T | C124S | 0.987 |
| 12:132604568:C:G | C83S | 0.987 |
| 12:132604569:A:T | C83S | 0.987 |
| 12:132604295:A:G | C146R | 0.986 |
| 12:132604293:G:C | C146W | 0.985 |
| 12:132604359:G:C | C124W | 0.985 |
| 12:132604360:C:T | C124Y | 0.985 |
| 12:132604478:C:G | C113S | 0.985 |
| 12:132604479:A:T | C113S | 0.985 |
| 12:132604264:C:G | C156S | 0.984 |
| 12:132604265:A:T | C156S | 0.984 |
| 12:132604797:C:G | C47S | 0.984 |
| 12:132604798:A:T | C47S | 0.984 |
| 12:132604504:G:C | C104W | 0.982 |
| 12:132604506:A:G | C104R | 0.982 |
| 12:132604551:A:G | C89R | 0.982 |
dbSNP variants (sampled 300 via entrez): RS1000252968 (12:132605140 CAGG>C), RS1000479696 (12:132610307 C>T), RS1000549715 (12:132604110 G>A,C,T), RS1000663519 (12:132608726 C>T), RS1000735287 (12:132608978 C>T), RS1000783799 (12:132611042 G>A), RS1000988948 (12:132606133 T>C,G), RS1001318102 (12:132610658 C>T), RS1001824927 (12:132605740 CTCTCTT>C), RS1001877904 (12:132608313 G>A), RS1001985301 (12:132603708 G>A,C), RS1002246960 (12:132608106 A>G), RS1002548763 (12:132606134 G>C), RS1002635901 (12:132610771 C>T), RS1003257523 (12:132611375 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_3 | Body mass index | 6.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aflatoxin B2 | increases methylation | 1 |
| Silicon Dioxide | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Propofol | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.